Rohit Chandwani, M.D., Ph.D. is an Assistant Professor in the Division of Liver Transplantation, Hepatobiliary and Pancreatic Surgery in the Department of Surgery and in the Department of Cell and Developmental Biology at Weill Cornell Medicine.  He is also the Mildred F. and John T. Rasweiler Scholar in Cancer Research in the Meyer Cancer Center and the Frank Glenn Faculty Scholar in the Department of Surgery.

Dr. Chandwani received his undergraduate degree in Economics from Harvard University and his MD at the Yale University School of Medicine. He then trained in General Surgery at Columbia University Medical Center and in Surgical Oncology at Memorial Sloan Kettering Cancer Center. Since 2017, his clinical practice as an attending surgeon at Weill Cornell Medicine focuses on the surgical treatment of pancreatic and liver disease.

Dr. Chandwani is also Principal Investigator of the Laboratory of Cancer Epigenetics where he studies the epigenetic dysregulation underlying inflammation, tumor initiation, and cancer progression. His laboratory is known for the application of chromatin-based tools to interrogate cell fate in the development of pancreatic neoplasia. Dr. Chandwani earned his Ph.D. from The Rockefeller University in the laboratory of Alexander Tarakhovsky studying epigenetic control of inflammation and innate immunity and was a postdoctoral fellow in the laboratory of Steven D. Leach at MSKCC, where he developed tools to interrogate chromatin in pancreatic cancer. In his laboratory, he has received grants from the National Cancer Institute (NCI), the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), the American Association for Cancer Research (AACR), the Emerson Collective Cancer Research Fund, the American Surgical Association, and the Pancreatic Cancer Action Network, and his work has been published in top-tier journals including Nature, Cancer Cell, and Developmental Cell.